GlobeNewswire 3/28 Triller, Who Recently Announced a Go-Public Transaction With Nasdaq Listed SEAC, to Acquire Fast-Gro...
GlobeNewswire 3/28 HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights fo...
GlobeNewswire 3/25 Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patient...
GlobeNewswire 3/24 Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
GlobeNewswire 3/24 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its...
GlobeNewswire 3/23 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire 3/21 Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpora...
GlobeNewswire 3/18 Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease Presented At The AD/PD Interna...
GlobeNewswire 3/17 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire 3/17 Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
GlobeNewswire 3/15 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
GlobeNewswire 3/10 Assembly Biosciences Reports Fourth Quarter and Year End 2021 Financial Results and Recent Highlight...
GlobeNewswire 3/10 Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpor...
GlobeNewswire 3/8 Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
GlobeNewswire 3/8  Inventiva announces that its IND application for the Phase II combination trial with lanifibranor a...
GlobeNewswire 3/7 Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and ...
GlobeNewswire 3/7 Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et ce...
GlobeNewswire 3/4 Morphic Announces Participation In Cowen 42nd Annual Healthcare Conference
GlobeNewswire 3/3 Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
GlobeNewswire 3/2 Harpoon Therapeutics Receives FDA Fast Track Designation for HPN217
GlobeNewswire 3/1 Miromatrix Names Jim Douglas as New Chief Financial Officer
GlobeNewswire 3/1 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...
GlobeNewswire 3/1 Inventiva announces participation at several conferences in March 2022
GlobeNewswire 2/28 Inventiva announces the schedule of publication and presentation of its 2021 Full-Year Financial Res...
GlobeNewswire 2/28 CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference